Another Potential COVID-19 Vaccine Shows Promising Results in Midstage Clinical Trials
AstraZeneca says vaccine developed with University of Oxford produced strong immune response in young and old volunteersArticles similaires à Another Potential COVID-19 Vaccine Shows Promising Results in Midstage Clinical Trials
Ireland awaits another Covid-19 vaccine after EMA approves Novavax
Ireland is ready to get another Covid-19 vaccine after the European Medicines Agency gave the...Oxford-AstraZeneca Researchers Halt Clinical Trial of COVID-19 Vaccine Among Children /
Two-shot vaccine developed jointly between British university and British-Swedish drugmaker under scrutiny over possible links to blood clotsActualités similaires
International Study Shows COVID-19 Vaccine Likely Uptake on the Rise
CDC endorses Johnson & Johnson one-dose vaccine for use in USActualités similaires
Pfizer COVID-19 Vaccine as Effective in General Use as in Trials, Israeli Researchers Say
Results revealed in first analysis of national COVID-19 vaccination strategyAustralia Abandons COVID-19 Vaccine Trials After False Positive HIV Results
Government urges public to have confidence in other treatments under developmentActualités similaires
British AstraZeneca to Conduct Another Trial Before Widely Distributing COVID-19 Vaccine
A spike in US infections has pushed hospitalizations to record levels/Actualités similaires
Third Potential COVID-19 Vaccine Shows Promising Results
AstraZeneca says vaccine developed with University of Oxford produced strong immune response in young and old volunteersActualités similaires
Another Potential COVID-19 Vaccine Shows Promising Results in Midstage Clinical Trials
AstraZeneca says vaccine developed with University of Oxford produced strong immune response in young and old volunteersActualités similaires
Asian Markets Mostly Higher as Euphoria Over Potential COVID-19 Vaccine Cools//
In futures trading, all three major US indices are trending negativelyActualités similaires
Asian Markets Mostly Higher as Optimism/Grows Over Potential New COVID-19 Vaccine
US indices are mixed in futures trading, with the Dow and the S&P 500 trading negatively, while the Nasdaq is slightly higherActualités similaires
Dow Closes at Record on News of Second Potential COVID-19 Vaccine
Investors cheered by Moderna's announcement of 95% effectiveness rate of experimental vaccineActualités similaires
European Markets Soar on News of Second Potential COVID-19 Vaccine
Investors buoyed by encouraging economic data from Japan and ChinaActualités similaires
Peru Set to Host Phase 3 of COVID-19 Vaccine Clinical Trials
Peru is seeking 3,500 participants in the multinational studyActualités similaires
European Financial Markets Reap Gains Sparked by Hopes of Potential COVID-19 Vaccine
Europe's benchmark indices were higher due to rising optimism over US drugmaker Pfizer's potential COVID-19 vaccineActualités similaires
Brazil Suspends Trials of COVID-19 Vaccine in its Final Trials Before Possible Approval
Brazil suspends trials of Chinese developed coronavirus vaccine after an adverse incident involving a volunteerActualités similaires
Pfizer Says COVID-19 Vaccine 90% Effective in Trials
Company, German partner say more testing is neededActualités similaires
Kenya Launches Human Trials of COVID-19 Vaccine
Amid calls for vaccine equity, Kenya joins global search for COVID cure/Actualités similaires
Britain Starts Accelerated Review for AstraZeneca's Potential COVID-19 Vaccine
AstraZeneca Plc says Britain's health regulator had started an accelerated review of its potential coronavirus vaccine
AstraZeneca Resumes Trials of COVID-19 Vaccine in Britain
Trials were suspended after a volunteer participant became illActualités similaires
Potential COVID-19 Vaccine Won't Be Compulsory, Australian Government Says
Australia has signed a deal with British drug maker AstraZeneca to produce and distribute the Oxford vaccine if it worksAustralia Reaches Deal to Secure Millions of Doses of Potential COVID-19 Vaccine//
Canberra makes agreement with Britain's AstraZeneca for 25 million doses of vaccine developed by University of OxfordUS Company to Begin Second Phase of Human Trials in South Africa for COVID-19 Vaccine
Second phase of human trials for COVID-19 vaccine underway in South Africa///Actualités similaires
US Makes Deal with Biotech Company for 100 Million Doses of Potential COVID-19 Vaccine
Trump's announcement comes hours after Russia announced formal approval of a coronavirus vaccineReport: Experimental COVID-19 Vaccine Shows Promising Immune Responses
Vaccine developed by federal scientists and manufactured by biotech firm Moderna first to be tested in humansActualités similaires
Global Markets Enjoy Boost on Promising News of COVID-19 Vaccine
All three U.S. indexes were trending positively in futures tradingActualités similaires
• Sources :
• Mots clés :
• Participer :
• Suivre l'actualité :
BACK TO TOP
